Analyzing the impact of 900 MHz EMF short-term exposure to the expression of 667 miRNAs in human peripheral blood cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 02 2021
Historique:
received: 11 07 2020
accepted: 28 12 2020
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 15 12 2021
Statut: epublish

Résumé

More than ever before, people around the world are frequently exposed to different sections of the electromagnetic spectrum, mainly emitted from wireless modern communication technologies. Especially, the level of knowledge on non-thermal biological EMF effects remains controversial. New technologies allow for a more detailed detection of non-coding RNAs which affect the post-transcriptional control. Such method shall be applied in this work to investigate the response of human blood cells to electromagnetic irradiation. In this ex vivo in vitro study, we exposed peripheral blood cells from 5 male donors to a continuous wave of 900 MHz EMF for 0, 30, 60 and 90 min. Significant micro RNA (miRNA) expression changes (p ≤ 0.05) above or below the SHAM exposed samples were evaluated using a quantitative real time PCR platform for simultaneous detection of 667 miRNAs called low density array. Only significant miRNA expression changes which were detectable in at least 60% of the samples per exposure group were analyzed. The results were compared with data from room temperature + 2 °C (RT + 2 °C) samples (here referred to as hyperthermia) to exclude miRNA expression altered by hyperthermia. The validation study by using the same donors and study design was performed after an interval of 2 years. When analyzing a total of 667 miRNAs during the screening study, 2 promising candidate miRNAs were identified, which were down regulated almost twice and showed a complete separation from the unexposed control group (miR-194 at 30 min and miR-939 at 60 min). The p-values even survived the Bonferroni correction for multiple comparisons (p = 0.0007 and p = 0.004, respectively). None of these miRNAs were expressed at a second time point after EMF exposure. Following an alternative analysis approach, we examined for miRNAs revealing an expected significant association of differential miRNA expression with the dose-time EMF exposure product, separately for each donor. Donors 2 and 3 revealed 11 and 10 miRNA species being significantly associated with EMF exposure which differed significantly from the other donors showing a minor number of differentially expressed miRNAs and could identify donors 2 and 3 as particularly EMF-responsive. The measurements were repeated after 2 years. The number of expressed/non-expressed miRNAs was almost similar (97.4%), but neither the number nor the previously differentially expressed miRNAs could be reproduced. Our data neither support evidence of early changes at miRNA expression level in human whole blood cells after 900 MHz EMF exposure nor the identification of EMF-responsive individuals.

Identifiants

pubmed: 33627699
doi: 10.1038/s41598-021-82278-1
pii: 10.1038/s41598-021-82278-1
pmc: PMC7904780
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4444

Références

Br J Anaesth. 2000 Jan;84(1):28-32
pubmed: 10740543
Mol Cell. 2007 Jun 8;26(5):745-52
pubmed: 17540599
Int J Oncol. 2009 Jun;34(6):1661-8
pubmed: 19424585
Sci Rep. 2018 Jan 12;8(1):684
pubmed: 29330481
Methods Mol Biol. 2010;667:193-203
pubmed: 20827535
Bioelectromagnetics. 2008 May;29(4):312-23
pubmed: 18175331
Nat Genet. 2003 Nov;35(3):215-7
pubmed: 14528307
Nat Struct Mol Biol. 2009 May;16(5):492-8
pubmed: 19377482
J Radiat Res. 2011;52(2):185-92
pubmed: 21343680
Nat Genet. 2007 Mar;39(3):380-5
pubmed: 17259983
Bioelectromagnetics. 2011 May;32(4):302-11
pubmed: 21452360
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Mol Cell Biol. 2008 Apr;28(7):2167-74
pubmed: 18212054
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Biomarkers. 2018 May - Jun;23(4):315-327
pubmed: 29297241
Adv Drug Deliv Rev. 2015 Jun 29;87:3-14
pubmed: 25979468
Genome Res. 2004 Oct;14(10A):1902-10
pubmed: 15364901
Transfusion. 2010 Jul;50(7):1581-8
pubmed: 20158686
Cell Cycle. 2007 Jul 1;6(13):1586-93
pubmed: 17554199
Proteomics. 2006 Sep;6(17):4732-8
pubmed: 16888767
Transfus Med Rev. 2011 Jul;25(3):247-51
pubmed: 21419598
Cell Cycle. 2016;15(3):357-67
pubmed: 26637059
J Cell Biol. 2006 Apr 24;173(2):195-206
pubmed: 16618811
Radiat Res. 2018 May;189(5):529-540
pubmed: 29509058
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
pubmed: 16885212
Radiat Res. 2018 Sep;190(3):226-235
pubmed: 29923790
Health Phys. 2014 Jun;106(6):664-76
pubmed: 24776898
Science. 2005 Sep 23;309(5743):2010-3
pubmed: 16179466
Int J Mol Med. 2007 Apr;19(4):607-15
pubmed: 17334636

Auteurs

Andreas Lamkowski (A)

Bundeswehr Institute of Radiobiology Affiliated To University Ulm, Neuherbergstr. 11, 80937, Munich, Germany. andreaslamkowski@bundeswehr.org.

Matthias Kreitlow (M)

Bundeswehr Research Institute for Protective Technologies and CBRN Protection, Humboldtstraße 100, 29633 Munster, Germany.

Jörg Radunz (J)

Bundeswehr Research Institute for Protective Technologies and CBRN Protection, Humboldtstraße 100, 29633 Munster, Germany.

Martin Willenbockel (M)

Bundeswehr Research Institute for Protective Technologies and CBRN Protection, Humboldtstraße 100, 29633 Munster, Germany.

Marcus Stiemer (M)

Bundeswehr, Helmut Schmidt University/University of the Federal Armed Forces, Holstenhofweg 85, 22043 Hamburg, Germany.

Lars Ole Fichte (LO)

Bundeswehr, Helmut Schmidt University/University of the Federal Armed Forces, Holstenhofweg 85, 22043 Hamburg, Germany.

Carl Friedrich Rädel (CF)

Bundeswehr, Helmut Schmidt University/University of the Federal Armed Forces, Holstenhofweg 85, 22043 Hamburg, Germany.

Matthäus Majewski (M)

Bundeswehr Institute of Radiobiology Affiliated To University Ulm, Neuherbergstr. 11, 80937, Munich, Germany.

Patrick Ostheim (P)

Bundeswehr Institute of Radiobiology Affiliated To University Ulm, Neuherbergstr. 11, 80937, Munich, Germany.

Matthias Port (M)

Bundeswehr Institute of Radiobiology Affiliated To University Ulm, Neuherbergstr. 11, 80937, Munich, Germany.

Michael Abend (M)

Bundeswehr Institute of Radiobiology Affiliated To University Ulm, Neuherbergstr. 11, 80937, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH